Literature DB >> 17654697

Pharmacokinetics and metabolism of neferine in rats after a single oral administration.

Ying Huang1, Yun Bai, Libo Zhao, Ting Hu, Benrong Hu, Jialing Wang, Jizhou Xiang.   

Abstract

The present study utilized HPLC and LC-MS approaches to investigate the pharmacokinetics and metabolism of neferine (a bisbenzylisoquinoline alkaloid). The plasma concentration-time curves of neferine (10, 20 and 50 mg/kg, i.g.) showed double absorption peaks with the first peak at 10 min and the second peak at 1 h. The t(1/2) (beta) was 15.6 h, 22.9 h and 35.5 h, for each of these doses, respectively. Neferine distributed rapidly into different organ systems, with the highest concentrations found in the liver, followed by the lung, kidney and heart at doses of 10 or 20 mg/kg. At 50 mg/kg dose, concentrations of the kidney and lung were higher than those of others. Moreover, this compound was mainly metabolized in the liver and converted partially by CYP2D6 to liensinine, isoliensinine, desmethyl-liensinine and desmethyl-isoliensinine. (c) 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654697     DOI: 10.1002/bdd.556

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  10 in total

1.  Neferine Protects Against Brain Damage in Permanent Cerebral Ischemic Rat Associated with Autophagy Suppression and AMPK/mTOR Regulation.

Authors:  Jirakhamon Sengking; Chio Oka; Piyawadee Wicha; Nuttapong Yawoot; Jiraporn Tocharus; Waraluck Chaichompoo; Apichart Suksamrarn; Chainarong Tocharus
Journal:  Mol Neurobiol       Date:  2021-09-08       Impact factor: 5.590

2.  Effects of neferine on retinal tissue in experimental diabetic rat model.

Authors:  Mehmet Cevik; Hamidu Hamisi Gobeka; Orhan Aydemir
Journal:  Int Ophthalmol       Date:  2022-07-19       Impact factor: 2.029

Review 3.  Lotus (Nelumbo nucifera Gaertn.) and Its Bioactive Phytocompounds: A Tribute to Cancer Prevention and Intervention.

Authors:  Anupam Bishayee; Palak A Patel; Priya Sharma; Shivani Thoutireddy; Niranjan Das
Journal:  Cancers (Basel)       Date:  2022-01-21       Impact factor: 6.575

Review 4.  Isoliensinine: A Natural Compound with "Drug-Like" Potential.

Authors:  Yan Cheng; Hong-Li Li; Zi-Wei Zhou; Hui-Zhi Long; Hong-Yu Luo; Dan-Dan Wen; Lin Cheng; Li-Chen Gao
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

5.  Neferine, an Alkaloid from Lotus Seed Embryos, Exerts Antiseizure and Neuroprotective Effects in a Kainic Acid-Induced Seizure Model in Rats.

Authors:  Tzu-Yu Lin; Chih-Yu Hung; Kuan-Ming Chiu; Ming-Yi Lee; Cheng-Wei Lu; Su-Jane Wang
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

6.  Identification of three new N-demethylated and O-demethylated bisbenzylisoquinoline alkaloid metabolites of isoliensinine from dog hepatic microsomes.

Authors:  Hui Zhou; Liping Li; Huidi Jiang; Su Zeng
Journal:  Molecules       Date:  2012-10-01       Impact factor: 4.411

7.  Neferine Attenuates Acute Kidney Injury by Inhibiting NF-κB Signaling and Upregulating Klotho Expression.

Authors:  Huihui Li; Wenhang Chen; Yusa Chen; Qiaoling Zhou; Ping Xiao; Rong Tang; Jing Xue
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

8.  In Vivo Efficacy and Metabolism of the Antimalarial Cycleanine and Improved In Vitro Antiplasmodial Activity of Semisynthetic Analogues.

Authors:  Fidelia Ijeoma Uche; Xiaozhen Guo; Jude Okokon; Imran Ullah; Paul Horrocks; Joshua Boateng; Chenggang Huang; Wen-Wu Li
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

9.  HPLC-MS/MS analysis of a traditional Chinese medical formulation of Bu-Yang-Huan-Wu-Tang and its pharmacokinetics after oral administration to rats.

Authors:  Lee-Hsin Shaw; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 10.  Current Advances in the Metabolomics Study on Lotus Seeds.

Authors:  Mingzhi Zhu; Ting Liu; Mingquan Guo
Journal:  Front Plant Sci       Date:  2016-06-20       Impact factor: 5.753

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.